首页|基于抗体的特发性炎性肌病患者外周血基因表达谱分析

基于抗体的特发性炎性肌病患者外周血基因表达谱分析

Antibody-based gene expression profiling of peripheral blood from patients with idiopathic inflamma-tory myopathy

扫码查看
目的 通过对抗黑色素瘤分化相关基因5(MDA5)抗体阳性和抗Jo-1抗体阳性的肌炎患者外周血单个核细胞(PBMCs)进行基因表达谱的分析,以阐明特发性炎性肌病亚型的病理生理学机制.方法 ①用Illumina HT-12 v4表达谱芯片对12例抗MDA5抗体阳性和16例抗Jo-1抗体阳性的肌炎患者及43名健康对照者的PBMCs进行基因表达谱筛查和分析.应用非配对t检验,经Benjamini-Hochberg校正,选取基因表达信号倍数变化的绝对值≥2且校正P<0.05为差异表达基因.将差异基因集进行基因本体论数据库(GO)功能富集分析和京都基因和基因组百科全书(KEGG)通路富集分析,以P<0.05作为显著性富集的阈值.②用实时荧光聚合酶链反应(real time-PCR)对差异表达基因进行验证,采用Kolmogorov-Smirnov 检验对连续型变量进行正态性检验,符合正态分布且方差齐性,采用单因素方差分析,不符合正态分布则用Kruskal-Wallis检验,P<0.05为差异有统计学意义.结果 ①分析抗MDA5抗体和抗Jo-1抗体阳性患者PBMCs的基因表达谱,发现2种肌炎亚型患者PBMCs的基因表达存在明显差异.抗MDA5抗体阳性患者特异性表达上调的差异基因为407个,GO功能富集分析主要富集于固有免疫应答(P<0.001)、病毒应答(P<0.001)和干扰素应答(P<0.001)等生物过程,KEGG通路富集分析主要富集于病毒感染相关通路(P<0.001)、视黄酸诱导基因Ⅰ(RIG-Ⅰ)样受体通路(P<0.001)和Toll样受体通路(P=0.002)等.抗MDA5抗体阳性组中特异性下调的259个差异基因,GO功能富集分析主要富集于免疫应答(P=0.006)、TGF-β受体信号通路(P=0.010)和自然杀伤细胞介导的免疫(P=0.015)等生物过程.抗Jo-1抗体阳性患者特异性表达上调的差异基因有162个,GO功能富集分析主要富集于核小体组装(P<0.001)、细胞增长的负调控(P=0.001)、凋亡负调控(P=0.004)和黏膜固有免疫(P=0.012)等生物过程,KEGG通路富集分析主要富集于代谢相关信号通路(P<0.001)和免疫相关通路(P<0.001)等.②Real time-PCR证实与健康对照组相比RIG-1样受体通路中的干扰素诱导的解旋酶C结构域1(IFIH1)(P=0.037)、干扰素刺激基因15(P<0.001)和 DEAD(Asp-Glu-Ala-Asp)盒多肽 58(DDX58)(P=0.032)以及人单核细胞趋化蛋白 1(MCP-1)(P<0.001)、人单核细胞趋化蛋白2(MCP-2)(P<0.001)和转录因子人碱性亮氨酸拉链转录因子激活蛋白1家族样转录因子2(BATF2)(P<0.001)、炎症信号通路相关的髓样分化因子88(MYD88)(P<0.001)在抗MDA5抗体阳性肌炎患者的PBMCs呈高表达.结论 抗MDA5抗体阳性患者PBMCs基因表达谱特征提示其发病机制与固有免疫应答、病毒应答和干扰素应答等生物过程密切相关.
Objective To elucidate the pathophysiological mechanisms of idiopathic inflammatory myopathy subtypes by analyzing the gene expression profiles of peripheral blood mononuclear cells(PBMCs)from anti-MDA5 antibody-positive and anti-Jo-1 antibody-positive myositis patients.Methods Gene expression profiling screening and analysis of PBMCs from 12 anti-MDA5 positive,16 anti-Jo-1 positive myositis patients and 43 healthy controls were performed using Illumina HT-12 v4 expression profiling microarrays.Applying the unpaired t test with Benjamini-Hochberg correction,the genes with the absolute value of fold change(FC)in gene expression signal ≥2 and adjusted P<0.05 were selected as differentially expressed genes.Differential gene sets were subjected to Gene Ontology(GO)functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis,with P<0.05 as the threshold for being significantly enriched.Validation of differentially expressed genes by real time-PCR.The Kolmogorov-Smimov test was used to test the normality of continuous variables.If the distribution was normal and the variance was homogeneous,analysis of variance(one-way ANOVA)was used.If the distribution was not normal,Kruskal-Wallis test was used,and P<0.05 was regarded as statistically significant difference.Results Analysis of gene expression profiles of PBMCs from patients with positive anti-MDA5 and anti-Jo-1 antibody revealed significant differences in gene expression of PBMCs from patients with the two myositis subtypes.The number of differentially expressed genes that specifically up-regulated in anti-MDA5 antibody positive patients was 407,and the GO functional enrichment analysis was mainly enriched in biological processes such as innate immune response(P<0.001),response to virus(P<0.001)and type Ⅰ interferon signaling pathway(P<0.001),and the KEGG pathway enrichment analysis was mainly enriched in the viral infection-associated pathway(P<0.001),RIG-Ⅰ like receptor signaling pathway(P<0.001)and Toll-like receptor signaling pathway(P=0.002),etc.The 259 differential genes specifically down-regulated in the anti-MDA5 antibody positive group were mainly enriched in biological processes such as immune response(P=0.006),TGF-β receptor signaling pathway(P=0.010)and natural killer cell mediated immunity(P=0.015)in GO functional enrichment analysis.There were 162 differentially expressed genes up-regulated specifically in anti-Jo-1 antibody positive patients,and GO functional enrichment analysis was mainly enriched in biological processes such as nucleosome assembly(P<0.001),negative regulation of cell growth(P=0.001),negative regulation of apoptotic process P=0.004),and innate immune response in mucosa(P=0.012),and the KEGG pathway enrichment analysis mainly enriched in metabolic-related signaling pathways(P<0.001)and immune-related pathways(P<0.001),etc.Real-time PCR confirmed that IFIH1(P=0.037),ISG15(P=0.003),and DDX58(P=0.032)in the RIG-Ⅰ-like receptor pathway as well as chemokines MCP-1(P=0.003),MCP-2(P<0.001),and transcription factor BATF2(P=0.002),and inflammatory signaling pathway-associated MYD88(P<0.001)were highly expressed in PBMCs from anti-MDA5 antibody-positive myositis patients.Conclusion The gene expression profile of PBMCs in anti-MDA5 antibody-positive patients suggests that the pathogenesis of patients with anti-MDA 5 antibody positive is closely related to biological processes such as innate immune response,viral infection,and interferon response.

MyositisAutoantibodiesGene expression profilingMicrochip analytical proceduresInterferon-stimulated genesRIG-Ⅰ like receptors

李牧原、王莉、李全贞、罗卉、张华莉

展开 >

中南大学湘雅医院风湿免疫科,长沙 410008

中南大学基础医学院病理生理学系,长沙 410013

肌炎 自身抗体 基因表达谱 芯片分析技术 干扰素刺激基因 RIG-Ⅰ样受体

国家自然科学基金

82070018

2024

中华风湿病学杂志
中华医学会

中华风湿病学杂志

CSTPCD
影响因子:0.651
ISSN:1007-7480
年,卷(期):2024.28(1)
  • 18